Healthcare -
Biotechnology - NASDAQ - US
$ 9.97
-0.103 %
$ 460 M
Market Cap
-3.26
P/E
URGN - DEPRECIATION & AMORTIZATION
Depreciation & Amortization URGN - UroGen Pharma Ltd.
1.19 M
LAST VALUE
-19.21%
2 YEAR CAGR
-2.18%
5 YEAR CAGR
44.44%
10 YEAR CAGR